StockNews.AI

Earnings

The company has reported earnings that exceed or miss market expectations, resulting in drastic price shift
Typical direction
Depends
Signal relevance
High
Event signals
1 min delayed

Recent public signals classified as Earnings, with first-party permanent pages for source and price-impact review.

BIOXSep 14, 2026-5.53% since signal

Bioceres posts stable 4Q results amid litigation and PFG foreclosure headwinds

Bioceres Crop Solutions reported 4Q26 revenue of $55.9 million and FY26 revenue of $238.3 million, while contending with ongoing creditor litigation and a January 2026 foreclosure auction of its Pro Farm Group. Despite cost reductions driving a positive Adjusted EBITDA in 4Q26, the Seeds reconfiguration and HB4-related activity weighed on full-year profitability. Management stated a focused roadmap for 2027 centered on portfolio rationalization, go-to-market realignment, and liquidity improvements.

View signal analysis
UROYSep 14, 2026+0.94% since signal

Uranium Royalty reports strong Q1 2027 results driven by Sweetwater

Uranium Royalty Corp. delivered a solid Q1 FY2027, selling 593,255 lbs of U3O8 for $51.0 million at $86 per pound and lifting net income to $16.3 million ($0.10 per share). The Sweetwater acquisition closed in July 2026, expanding its diversified royalty platform and lifting the company's landholdings to over 5.3 million acres, enhancing long-term cash flow and optionality across uranium, critical minerals, and energy.

View signal analysis
TSXVHITISep 14, 2026

High Tide Q3 2026: record revenue, aggressive expansion underpins growth

High Tide posted a Q3 2026 revenue of $198.8 million, with record gross profit and Adjusted EBITDA, signaling improving operating leverage. The company highlighted Remexian’s Germany growth, Canna Cabana’s 232 Canadian stores, and strategic Ontario acquisitions, alongside a $40 million secured debt facility to fund expansion, reinforcing an approaching $800 million annualized revenue run rate.

View signal analysis
KMTSSep 14, 2026+4.66% since signal

Kestra Medical Advances Q1 Results, Raises FY27 Revenue Guidance

Kestra reported F1Q27 revenue of $31.0M, up 60% year over year, with a gross margin of 56.5%. Management raised FY27 revenue guidance to $141M, signaling durable demand from the WCD market and in-network patients. Net liquidity remains robust (~$320M including committed loan availability), though GAAP net loss persisted, highlighting ongoing investment in commercialization and R&D.

View signal analysis
HUBGSep 14, 2026-6.66% since signal

Hub Group Provides Preliminary 1H26 Results; Restatement Underway and Nasdaq Risk

Hub Group reported preliminary, unaudited results for the first half of 2026 and updated on its restatement process. Revenue through 1H26 is guided at about $1.70–$1.80 billion, with costs from fuel, rail and drayage pressuring ITS and Logistics. A new efficiency program aims to lift margins, while Nasdaq listing risk adds near-term volatility until the restatement and filing timeline are resolved.

View signal analysis
FCPTSep 11, 2026-0.38% since signal

FCPT raises quarterly dividend 3.5% for Q4 2026

Four Corners Property Trust announced a 3.5% monthly dividend increase to $0.1265 per share for Q4 2026, resulting in an annualized payout of $1.518. The move reinforces FCPT's income-focused strategy as a restaurant/retail REIT. The higher cash return could attract yield-oriented buyers and support modest near-term upside, assuming dividend sustainability.

View signal analysis